Condition: Basilar Artery Occlusion · Large Ischemic Core · Large Core Infarct · Sponsor: The First Affiliated Hospital of Hainan Medical University
A multicenter, prospective, open-label, blinded endpoint, randomized controlled trial designed to evaluate the efficacy and safety of best medical management (BMM) combined with endovascular treatment (EVT) versus BMM alone in acute basilar artery occlusion (BAO) patients with large infarct cores.
This description comes directly from the study's public registry record.
Zhengqiang Zhao, PhD · 8613976015677 · zhenqiang.zhao@qq.com
Wen Sun, PhD · 8615050589620 · sunwen_medneuro@163.com
Always discuss trial participation with your own doctor first.
| First Affiliated Hospital of Hainan Medical University | Haikou, Hainan, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07090941